Collectively, this study revealed miR-6750 was specific dysregulated in NPC-SEVs but not in serum, and miR-6750-SEVs can remodel TME to modulate NPC metastasis by directing targeting M6PR. The gene discussed is M6PR; the disease is nasopharyngeal carcinoma.